维普中文期刊产品整合服务
296篇 您的检索式:作者名="Reck M"
    题名 作者 年代 出处 被引量
1Phase III trial of cispl-atin plus gemcitabine with either placebo or bevacizumab asfirst-line therapy for nonsquamous non-small-cell lung cancer:Avail显示文摘Reck M von Pawel J Zatloukal P 2009J Clin Oncol2009,27,8:1
2Final safety results of BO17704(A-VAiL):a phase III randomized study of first-line bevacizumab(BV)and cisplatin/gemcitabine(CG)in patients(pts)with ad-vanced or recurrent nonsquamous non-small cell lung cancer(NSCLC)显示文摘Hirsh V Ramlau R von Pawel J Zatloukal P Vera G Leighl N Mezger J Archer V Reck M 2009J Clin Oncol2009,,:1
3Risk of symptomatic central nervous system (CNS) progression and secondary hemorrhage in patients with non-squamous non-small cell lung cancer (NSCLC) receiving bevacizumab ( BV ) -based first-line therapy 显示文摘Archer V Reck M Sandier AB 2008J Clin Oncol2008,26,:1
4Management of non-small-cell lung cancer: recent developments显示文摘Reck M Heigener DF Mok T 2013Lancet2013,382,9893:1
5PhaseⅢtrial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-smallcell lung cancer:AVAil显示文摘Reck M von Pawel J Zatloukal P 2009J Clin Oncol2009,27,8:1
6Overall survival with cispl- atin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAIL)显示文摘Reck M yon Pawel J Zatloukal P 2010Ann Oncol2010,21,9:1
7PhaseⅢ trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer:AVAil显示文摘Reck M von Pawel J Zatloukal P 0,,:1
8Phase El trial of cispl-atin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil显示文摘Reck M von Pawel J Zatloukal P 2009J Clin Oncol2009,27,8:1
9Examining the safety profile of angiogenesis inhibitors : im- plications for clinical practice 显示文摘Reck M 2010Target Oncol2010,5,4:1
10An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non- small cell lung cancer patients with brain metastases显示文摘Sandier A Hirsh V Reck M 2012Lung Cancer2012,78,1:1
11A Phase II double- blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer显示文摘Reck M Kaiser R Eschbach C 2011Ann Oncol2011,22,6:1
12Phase III trial of eisplatin plus gemcitabine with either placebo or bevaeizumab as firstline therapy for nonsquamous non-small-cell lung cancer: AVAil 显示文摘Reck M yon Pawel J Zatloukl P 2009J ClinOncol2009,27,8:1
13Phase Ⅲ trial of cisplatine plus gemcitabine with either placebo or bevaci- zumab as first-line therapy for nonsquamons non-small- cell lung cancer显示文摘Reck M von Rawel J Zatlonkal P 2009AVAil J Clin Onc2009,27,8:1
14EGFR/HER1 inhibition: an example of new targeted therapies in non-small cell lung cancer显示文摘Reck M Kranich AL Steinbach AK 2005Med Klin2005,100,12:1
15Carboplatin/paclitaxelwith/without sorafenib in chemonaive patients with stage IIIB/IV non-small cell lung cancer(NSCLC):Interim analysis(IA)results from a randomized phase III trial(ESCAPE)显示文摘Hanna N Von Pawel J Reck M 2008J Tho-rac Oncol2008,3,26:1
16Gefitinib in the treatment of advanced non-small-celllung cancer 显示文摘Reck M 2009Expert Rev Anticancer Ther2009,9,4:1
17Cur ent approaches in chemotherapy of advanced and metastatic non-smal cel lung cancer(NSCLC)显示文摘Reck M 0,,3:1
18Metastatic non-small- cell lung eaneer: ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up显示文摘DrAddario G Frah M Reck M 2010Ann Oneol2010,21,5:1
19Reversible digital and holographic optical storage in polymeric liquid crystals 显示文摘Eich M Wendroff J H Reck B 1987Makromol Chem Rapid Commun1987,8,:1
20Global stainless steel cycle exemplifies China' s rise to metal dominance显示文摘Reck B K Chambon M Hashimoto S 2010Environmental Science & Technology2010,44,10:1
返回顶部 每页显示:
共15页 首页 上一页 第1页 下一页 末页 /15 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费